Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503).
dc.contributor.author | Wiland, P | |
dc.contributor.author | Skinner, M | |
dc.contributor.author | Dember, LM | |
dc.contributor.author | Hauck, W | |
dc.contributor.author | Garceau, D | |
dc.contributor.author | Briand, R | |
dc.contributor.author | Lachmann, H | |
dc.contributor.author | Obici, L | |
dc.contributor.author | Gorevic, PD | |
dc.contributor.author | Hawkins, PN | |
dc.contributor.author | Butrimiene, I | |
dc.contributor.author | Lesnyak, O | |
dc.contributor.author | Livneh, A | |
dc.contributor.author | Filipowicz-Sosnowska, A | |
dc.contributor.author | Merlini, G | |
dc.contributor.author | DİRESKENELİ, RAFİ HANER | |
dc.contributor.author | Benson, MD | |
dc.contributor.author | Dispenzieri, A | |
dc.contributor.author | GÜL, Ahmet | |
dc.contributor.author | Hazenberg, BPC | |
dc.date.accessioned | 2022-02-18T10:29:56Z | |
dc.date.available | 2022-02-18T10:29:56Z | |
dc.identifier.citation | Gorevic P., Hawkins P., Butrimiene I., Lesnyak O., Livneh A., Filipowicz-Sosnowska A., Merlini G., DİRESKENELİ R. H. , Benson M., Dispenzieri A., et al., "Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503).", 69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 12 - 17 Kasım 2005, cilt.52, ss.4108-4109 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a0f7e1f3-4e00-49cf-b16b-6296be57fabd | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/179355 | |
dc.language.iso | eng | |
dc.subject | Rheumatology | |
dc.subject | Health Sciences | |
dc.subject | Sağlık Bilimleri | |
dc.subject | ROMATOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.title | Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503). | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 52 | |
dc.contributor.firstauthorID | 3141847 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]